Skip to main content

Want a detailed portfolio tracker?

Vera Therapeutics (VERA) Income Statement (2020 - 2026)

Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Vera Therapeutics (VERA).

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Reported currency: USD
Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020
Operating Expenses
Research And Development
86M
(+45.02%)
59M
(+5.03%)
56M
(-2.97%)
58M
(+40.99%)
41M
(+23.78%)
33M
(-17.27%)
40M
(+37.53%)
29M
(+26.34%)
23M
(+11.59%)
21M
(+29.13%)
16M
(-0.80%)
16M
(-35.36%)
25M
(-5.88%)
27M
(+35.71%)
20M
(+94.46%)
10M
(-19.44%)
13M
(-1.57%)
13M
(+258.15%)
3.56M
(+9.88%)
3.24M
(+10.58%)
2.93M
(-92.65%)
40M
(+1922.34%)
1.97M
(+1.03%)
1.95M
(+35.42%)
1.44M
Selling General And Administrative
39M
(+12.09%)
35M
(+27.09%)
27M
(+25.10%)
22M
(+37.88%)
16M
(+2.25%)
16M
(+64.07%)
9.49M
(+18.18%)
8.03M
(+1.52%)
7.91M
(+26.76%)
6.24M
(+10.25%)
5.66M
(-1.39%)
5.74M
(-6.67%)
6.15M
(-11.00%)
6.91M
(+23.61%)
5.59M
(+12.93%)
4.95M
(+10.74%)
4.47M
(+16.71%)
3.83M
(+3.79%)
3.69M
(+41.38%)
2.61M
(+46.63%)
1.78M
(+56.14%)
1.14M
(+75.38%)
650K
(-46.72%)
1.22M
(+18.45%)
1.03M
Operating Expenses
125M
(+32.82%)
94M
(+12.25%)
84M
(+4.73%)
80M
(+40.13%)
57M
(+16.93%)
49M
(-1.79%)
50M
(+33.37%)
37M
(+20.03%)
31M
(+15.09%)
27M
(+24.22%)
22M
(-0.96%)
22M
(-29.72%)
31M
(-6.91%)
34M
(+33.04%)
25M
(+67.60%)
15M
(-11.52%)
17M
(+2.59%)
17M
(+128.83%)
7.25M
(+23.93%)
5.85M
(+23.94%)
4.72M
(-88.91%)
43M
(+953.47%)
4.04M
(+27.44%)
3.17M
(+28.34%)
2.47M
Depreciation And Amortization
140K
(-63.16%)
380K--90K
(0.00%)
90K--10K
(-50.00%)
20K---------------
Operating Income
Operating Income
-125.13M
(+32.82%)
-94.21M
(+12.25%)
-83.93M
(+4.73%)
-80.14M
(+40.13%)
-57.19M
(+16.93%)
-48.91M
(-1.79%)
-49.80M
(+33.37%)
-37.34M
(+20.03%)
-31.11M
(+15.09%)
-27.03M
(+24.22%)
-21.76M
(-0.96%)
-21.97M
(-29.72%)
-31.26M
(-6.91%)
-33.58M
(+33.04%)
-25.24M
(+67.60%)
-15.06M
(-11.52%)
-17.02M
(+2.65%)
-16.58M
(+128.69%)
-7.25M
(+23.93%)
-5.85M
(+23.94%)
-4.72M
(-88.91%)
-42.56M
(+953.47%)
-4.04M
(+27.44%)
-3.17M
(+28.34%)
-2.47M
Ebit
-125.13M
(+32.82%)
-94.21M
(+12.25%)
-83.93M
(+4.73%)
-80.14M
(+40.13%)
-57.19M
(+16.93%)
-48.91M
(-1.79%)
-49.80M
(+33.37%)
-37.34M
(+20.03%)
-31.11M
(+15.09%)
-27.03M
(+24.22%)
-21.76M
(-0.96%)
-21.97M
(-29.72%)
-31.26M
(-6.91%)
-33.58M
(+33.04%)
-25.24M
(+67.60%)
-15.06M
(-11.52%)
-17.02M
(+2.65%)
-16.58M
(+128.69%)
-7.25M
(+23.93%)
-5.85M
(+23.94%)
-4.72M
(-88.91%)
-42.56M
(+953.47%)
-4.04M
(+27.44%)
-3.17M
(+28.34%)
-2.47M
EBITDA
-124.99M
(+19.14%)
-104.91M
(+33.93%)
-78.33M
(+4.92%)
-74.66M
(+30.73%)
-57.11M
(-3.97%)
-59.47M
(+33.04%)
-44.70M
(+40.57%)
-31.80M
(+2.25%)
-31.10M
(-9.57%)
-34.39M
(+79.49%)
-19.16M
(-0.47%)
-19.25M
(-34.05%)
-29.19M
(-8.32%)
-31.84M
(+29.80%)
-24.53M
(+66.64%)
-14.72M
(-13.26%)
-16.97M
(+0.83%)
-16.83M
(+121.16%)
-7.61M
(+121.22%)
-3.44M
(-26.96%)
-4.71M
(-89.01%)
-42.86M
(+874.09%)
-4.40M
(+24.29%)
-3.54M
(+44.49%)
-2.45M
Other Income / Expenses
Interest Income
6.36M
(+15.22%)
5.52M
(-3.83%)
5.74M
(-9.18%)
6.32M
(-8.54%)
6.91M
(+3.75%)
6.66M
(+39.92%)
4.76M
(-6.67%)
5.10M
(+21.72%)
4.19M
(+113.78%)
1.96M
(-9.26%)
2.16M
(-3.57%)
2.24M
(+38.27%)
1.62M
(+82.02%)
890K
(+56.14%)
570K
(+119.23%)
260K
(+766.67%)
30K
(+200.00%)
10K
(0.00%)
10K-----10K
Interest Expense
1.82M
(-4.71%)
1.91M
(-2.55%)
1.96M
(+4.81%)
1.87M
(+4.47%)
1.79M
(-4.28%)
1.87M
(-3.61%)
1.94M
(+1.57%)
1.91M
(0.00%)
1.91M
(+80.19%)
1.06M
(+12.77%)
940K
(+3.30%)
910K
(+4.60%)
870K
(+45.00%)
600K
(+300.00%)
150K
(+15.38%)
130K
(+8.33%)
120K
(+500.00%)
20K---20K
(-66.67%)
60K
(0.00%)
60K
(+200.00%)
20K
Net Interest Income
6.36M
(+15.22%)
5.52M
(-3.83%)
5.74M
(-9.18%)
6.32M
(-8.54%)
6.91M
(-34.06%)
10M
(+120.17%)
4.76M
(+49.22%)
3.19M
(+39.91%)
2.28M
(+153.33%)
900K
(-26.23%)
1.22M
(-8.27%)
1.33M
(+77.33%)
750K
(+150.00%)
300K
(-28.57%)
420K
(+200.00%)
140K-90.00K
(+800.00%)
-10.00K10K---10.00K
(-83.33%)
-60.00K
(0.00%)
-60.00K
(+200.00%)
-20.00K
Other Non Operating Income
4.10M
(-74.15%)
16M
(+335.71%)
3.64M
(+0.83%)
3.61M
(-34.36%)
5.50M
(-63.38%)
15M
(+373.82%)
3.17M
(-12.91%)
3.64M
(+33.33%)
2.73M
(-54.65%)
6.02M
(+264.85%)
1.65M
(-8.84%)
1.81M
(+52.10%)
1.19M
(-35.68%)
1.85M
(+230.36%)
560K
(+180.00%)
200K-60.00K1.79M-360.00K2.41M--1.17M
(+178.57%)
-420.00K
(-2.33%)
-430.00K-
Net Income
Income Before Tax
--299.61M----152.15M----95.99M----89.05M----32.61M----53.41M---
Net Income From Continuing Operations
-121.03M
(+32.85%)
-91.10M
(+13.46%)
-80.29M
(+4.91%)
-76.53M
(+48.06%)
-51.69M
(+19.05%)
-43.42M
(-6.88%)
-46.63M
(+38.33%)
-33.71M
(+18.78%)
-28.38M
(+10.64%)
-25.65M
(+27.61%)
-20.10M
(-0.30%)
-20.16M
(-32.96%)
-30.07M
(-7.31%)
-32.44M
(+31.44%)
-24.68M
(+66.20%)
-14.85M
(-13.06%)
-17.08M
(+1.36%)
-16.85M
(+121.42%)
-7.61M
(+121.22%)
-3.44M
(-26.96%)
-4.71M
(-89.01%)
-42.87M
(+861.21%)
-4.46M
(+23.89%)
-3.60M
(+45.75%)
-2.47M
Net Income
-121.03M
(+32.85%)
-91.10M
(+13.46%)
-80.29M
(+4.91%)
-76.53M
(+48.06%)
-51.69M
(+19.05%)
-43.42M
(-6.88%)
-46.63M
(+38.33%)
-33.71M
(+18.78%)
-28.38M
(+10.64%)
-25.65M
(+27.61%)
-20.10M
(-0.30%)
-20.16M
(-32.96%)
-30.07M
(-7.31%)
-32.44M
(+31.44%)
-24.68M
(+66.20%)
-14.85M
(-13.06%)
-17.08M
(+1.36%)
-16.85M
(+121.42%)
-7.61M
(+121.22%)
-3.44M
(-26.96%)
-4.71M
(-89.01%)
-42.87M
(+861.21%)
-4.46M
(+23.89%)
-3.60M
(+45.75%)
-2.47M
Comprehensive Income Net Of Tax
-121.97M
(-59.24%)
-299.22M
(+274.31%)
-79.94M
(+4.28%)
-76.66M
(+49.06%)
-51.43M
(-66.17%)
-152.01M
(+236.75%)
-45.14M
(+32.84%)
-33.98M
(+17.95%)
-28.81M
(-69.91%)
-95.74M
(+377.74%)
-20.04M
(-1.28%)
-20.30M
(-31.99%)
-29.85M
(-66.57%)
-89.28M
(+259.85%)
-24.81M
(+65.51%)
-14.99M---------